These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7638469)

  • 1. Chemoprevention of prostate cancer.
    Thompson IM; Coltman CA; Brawley OW; Ryan A
    Semin Urol; 1995 May; 13(2):122-9. PubMed ID: 7638469
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemoprevention of prostate cancer.
    Brawley OW; Thompson IM
    Urology; 1994 May; 43(5):594-9. PubMed ID: 8165761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate cancer prevention: review of target populations, pathological biomarkers, and chemopreventive agents.
    Montironi R; Mazzucchelli R; Marshall JR; Bartels PH
    J Clin Pathol; 1999 Nov; 52(11):793-803. PubMed ID: 10690166
    [No Abstract]   [Full Text] [Related]  

  • 4. Update on prostate cancer chemoprevention.
    Lowe JF; Frazee LA
    Pharmacotherapy; 2006 Mar; 26(3):353-9. PubMed ID: 16503715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoprevention: an important treatment option for prostate cancer.
    Calvert RC; Thompson CS; Mikhailidis DP; Morgan RJ
    J R Soc Promot Health; 2000 Sep; 120(3):146-7. PubMed ID: 11077795
    [No Abstract]   [Full Text] [Related]  

  • 6. Can prostate cancer be prevented?
    Klein EA
    Nat Clin Pract Urol; 2005 Jan; 2(1):24-31. PubMed ID: 16474573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in prostate cancer chemoprevention: a translational perspective.
    Nambiar D; Singh RP
    Nutr Cancer; 2013; 65 Suppl 1():12-25. PubMed ID: 23682779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prostate cancer prevention].
    Wisard M; Leisinger HJ
    Rev Med Suisse; 2006 Jan; 2(48):163-5. PubMed ID: 16463803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemoprevention of cancer of the prostate].
    Droz JP
    Bull Cancer; 1995 Jul; 82 Suppl 3():178s-180s. PubMed ID: 7492831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostatic intraepithelial neoplasia and prostate cancer.
    Montironi R; Santinelli A; Mazzucchelli R
    Panminerva Med; 2002 Sep; 44(3):213-20. PubMed ID: 12094135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer prevention: risk reduction through life-style, diet, and chemoprevention.
    Greco KE; Kulawiak L
    Oncol Nurs Forum; 1994 Oct; 21(9):1504-11. PubMed ID: 7816677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgens and prevention of prostate cancer.
    Sarvis JA; Thompson IM
    Curr Opin Endocrinol Diabetes Obes; 2008 Jun; 15(3):271-7. PubMed ID: 18438176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of disease: Prostate cancer--a model for cancer chemoprevention in clinical practice.
    Canby-Hagino ED; Thompson IM
    Nat Clin Pract Oncol; 2005 May; 2(5):255-61. PubMed ID: 16264961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoprevention of prostate cancer: the Prostate Cancer Prevention Trial.
    Thompson IM; Coltman CA; Crowley J
    Prostate; 1997 Nov; 33(3):217-21. PubMed ID: 9365551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Practical follow-up of a patient treated with finasteride in screening for prostate cancer].
    Villers A
    Prog Urol; 2008 Apr; 18 Suppl 3():S58-62. PubMed ID: 18455086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoprevention in prostate cancer.
    Parnes HL; Figg WD
    Pharmacotherapy; 2006 Oct; 26(10):1533; author reply 1533. PubMed ID: 16999665
    [No Abstract]   [Full Text] [Related]  

  • 17. The chemoprevention of prostate cancer and the Prostate Cancer Prevention Trial.
    Brawley OW; Thompson IM
    Cancer Treat Res; 1996; 88():189-200. PubMed ID: 9239480
    [No Abstract]   [Full Text] [Related]  

  • 18. Editorial comment on: Pharmacological approaches to reducing the risk of prostate cancer.
    Adolfsson J
    Eur Urol; 2009 May; 55(5):1074. PubMed ID: 19200637
    [No Abstract]   [Full Text] [Related]  

  • 19. Suppressive effects of antiandrogens, finasteride and flutamide on development of prostatic lesions in a transgenic rat model.
    Cho YM; Takahashi S; Asamoto M; Suzuki S; Tang M; Shirai T
    Prostate Cancer Prostatic Dis; 2007; 10(4):378-83. PubMed ID: 17457304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cost of prostate cancer chemoprevention: a decision analysis model.
    Svatek RS; Lee JJ; Roehrborn CG; Lippman SM; Lotan Y
    Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1485-9. PubMed ID: 16896037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.